318 related articles for article (PubMed ID: 21993917)
1. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
Mori S; Terada K; Ueki Y
Mod Rheumatol; 2012 Aug; 22(4):515-23. PubMed ID: 21993917
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
[TBL] [Abstract][Full Text] [Related]
3. Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil.
Turatti L; Sprinz E; Lazzaretti RK; Kuhmmer R; Agnes G; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; de Almeida S; Ribeiro JP; Mattevi VS
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1015-8. PubMed ID: 22050734
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency.
Park WB; Choe PG; Song KH; Jeon JH; Park SW; Kim HB; Kim NJ; Oh MD; Choe KW
Clin Infect Dis; 2010 Jul; 51(1):101-6. PubMed ID: 20504240
[TBL] [Abstract][Full Text] [Related]
5. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV-positive patients receiving Atazanavir: a systematic review.
Culley CL; Kiang TK; Gilchrist SE; Ensom MH
Ann Pharmacother; 2013 Apr; 47(4):561-72. PubMed ID: 23548653
[TBL] [Abstract][Full Text] [Related]
6. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
de Vries HS; Te Morsche RH; Jenniskens K; Peters WH; de Jong DJ
J Crohns Colitis; 2012 Jun; 6(5):597-602. PubMed ID: 22398043
[TBL] [Abstract][Full Text] [Related]
7. UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.
Chen Z; Su D; Ai L; Jiang X; Wu C; Xu Q; Wang X; Fan Z
Gene; 2014 Nov; 552(1):32-8. PubMed ID: 25200497
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
Peer CJ; Sissung TM; Kim A; Jain L; Woo S; Gardner ER; Kirkland CT; Troutman SM; English BC; Richardson ED; Federspiel J; Venzon D; Dahut W; Kohn E; Kummar S; Yarchoan R; Giaccone G; Widemann B; Figg WD
Clin Cancer Res; 2012 Apr; 18(7):2099-107. PubMed ID: 22307138
[TBL] [Abstract][Full Text] [Related]
9. Association between the UGT1A1*28 allele and hyperbilirubinemia in HIV-positive patients receiving atazanavir: a meta-analysis.
Du P; Wang A; Ma Y; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30962262
[No Abstract] [Full Text] [Related]
10. Analysis of uridine diphosphate glucuronosyl transferase 1A1 gene mutations in neonates with unconjugated hyperbilirubinemia.
Guo XH; Sun YF; Cui M; Wang JB; Han SZ; Miao J
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323053
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie PI; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO
Pharmacogenet Genomics; 2006 May; 16(5):321-9. PubMed ID: 16609363
[TBL] [Abstract][Full Text] [Related]
12. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.
Sugatani J; Yamakawa K; Yoshinari K; Machida T; Takagi H; Mori M; Kakizaki S; Sueyoshi T; Negishi M; Miwa M
Biochem Biophys Res Commun; 2002 Mar; 292(2):492-7. PubMed ID: 11906189
[TBL] [Abstract][Full Text] [Related]
13. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
[TBL] [Abstract][Full Text] [Related]
14. Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients.
Nomura A; Maruo Y; Taga T; Takeuchi Y
Pediatr Res; 2016 Aug; 80(2):252-7. PubMed ID: 27057738
[TBL] [Abstract][Full Text] [Related]
15. [Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].
Sun SC; Zhou ZM; Chen QR; Peng YS; Tu CQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):425-8. PubMed ID: 23926009
[TBL] [Abstract][Full Text] [Related]
16. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
17. Association between uridin diphosphate glucuronosylotransferase 1A1 (UGT1A1) gene polymorphism and neonatal hyperbilirubinemia.
Mazur-Kominek K; Romanowski T; Bielawski K; Kiełbratowska B; Preis K; Domżalska-Popadiuk I; Słomińska-Frączek M; Sznurkowska K; Renke J; Plata-Nazar K; Śledzińska K; Sikorska-Wiśniewska G; Góra-Gębka M; Liberek A
Acta Biochim Pol; 2017; 64(2):351-356. PubMed ID: 28399191
[TBL] [Abstract][Full Text] [Related]
18. Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia.
Abumiya M; Takahashi N; Niioka T; Kameoka Y; Fujishima N; Tagawa H; Sawada K; Miura M
Drug Metab Pharmacokinet; 2014; 29(6):449-54. PubMed ID: 24898899
[TBL] [Abstract][Full Text] [Related]
19. A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.
Danoff TM; Campbell DA; McCarthy LC; Lewis KF; Repasch MH; Saunders AM; Spurr NK; Purvis IJ; Roses AD; Xu CF
Pharmacogenomics J; 2004; 4(1):49-53. PubMed ID: 14647407
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors related to unconjugated hyperbilirubinemia amongst adults.
Huang CS; Huang MJ; Lin MS; Yang SS; Teng HC; Tang KS
Pharmacogenet Genomics; 2005 Jan; 15(1):43-50. PubMed ID: 15864125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
